Tracked deals
3
3 tracked deals across 2021-2023.
Operating Company
Healthcare
Kymanox
Morrisville, North Carolina, United States
Kymanox is a life sciences innovation partner delivering integrated engineering, scientific, compliance, and project management solutions that support the design, development, and commercialization of modern medicines and therapies.
- Focus Areas
- Human Factors / Usability Engineering, Regulatory Affairs / Regulatory Consulting, Quality Systems & Compliance
- Website
- www.kymanox.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
2 addon · 1 buyout
Kymanox Acquisition Volume by Year
Last 2 years
Supporting Data
Recent Transactions
-
March 24, 2023
- Buyer
- Kymanox Corporation
- Target
- Agilis Consulting Group
- Industry
- Healthcare Services
- Location
- Ohio, United States
- Type
- Addon
Kymanox, a PE-backed life sciences professional services firm, has acquired Agilis Consulting Group, a Cincinnati-based human factors and usability engineering consultancy. The transaction (terms undisclosed) expands Kymanox's human factors, regulatory strategy, and usability engineering capabilities to support medical device, combination product, and biologics clients globally.
-
February 2, 2023
- Buyer
- Kymanox Corporation
- Target
- anteris medical GmbH, anteris helvetia AG
- Industry
- Professional Services
- Location
- Bavaria, Germany
- Type
- Buyout
Kymanox Corporation has acquired anteris medical GmbH (Germany) and anteris helvetia AG (Switzerland) to expand its European footprint and broaden its life-science professional services capabilities. The deal brings additional regulatory, quality, and combination-product expertise to Kymanox; terms were not disclosed.
-
August 9, 2021
- Buyer
- Kymanox Corporation, WestView Capital Partners
- Target
- Neuma LLC
- Industry
- Medical Devices
- Location
- Pennsylvania, United States
- Type
- Addon
Kymanox Corporation, a life-sciences-focused professional services firm, has acquired Neuma LLC, an engineering services provider specializing in drug delivery devices and combination products. The deal — funded by a recent growth recapitalization from WestView Capital Partners — expands Kymanox's product development and combination-product capabilities to better support clients across biopharma and medical device markets.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
1 tracked deal by Kymanox.
Medical Devices Buyers & Acquisitions
1 tracked deal by Kymanox.
Professional Services Buyers & Acquisitions
1 tracked deal by Kymanox.
Acquisitions in Ohio
1 tracked deal by Kymanox.
Acquisitions in Pennsylvania
1 tracked deal by Kymanox.
Selling a company? Get in front of buyers like Kymanox
Turn tracked acquisition activity into an outreach-ready buyer list.